{
    "code": "52026385",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026385",
    "time": "2019-07-19 03:16:36",
    "許可證字號": "衛部藥輸字第026385號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/08\/25",
    "發證日期": "103\/08\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202638509",
    "中文品名": "佐骨實注射液4毫克\/100毫升",
    "英文品名": "Zoldria 4mg\/100ml solution for infusion",
    "適應症": "1.與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。2.治療惡性腫瘤之高血鈣併發症(HCM)。",
    "劑型": "270注射劑",
    "包裝": "100毫升塑膠瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "ZOLEDRONIC ACID MONOHYDRATE",
    "主製造廠": {
        "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
        "申請商地址": "新北市新店區寶中路119號4樓、5樓",
        "主製造廠": "",
        "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001630",
            "成分名稱": "ZOLEDRONIC ACID MONOHYDRATE",
            "含量描述": "(eq. to Zoledronic acid anhydrous 4mg)",
            "含量": "4.2642000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_026385_page2-104-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026385&Seq=002&Type=9"
        },
        {
            "title": "52026385-104-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026385&Seq=003&Type=8"
        }
    ]
}